Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway

Open Access

Peer-reviewed

Research Article

Brendan D. Looyenga ,

* E-mail: brendan.looyenga@vai.org

Affiliation Laboratory of Systems Biology, Van Andel Research Institute, Grand Rapids, Michigan, United States of America
⨯
James Resau,

Affiliation Program in Biospecimen Science, Van Andel Research Institute, Grand Rapids, Michigan, United States of America
⨯
Jeffrey P. MacKeigan

Affiliation Laboratory of Systems Biology, Van Andel Research Institute, Grand Rapids, Michigan, United States of America
⨯

Reader Comments (0)

Cell differentiation
Is the Subject Area "Cell differentiation" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Neuroblastoma cells
Is the Subject Area "Neuroblastoma cells" applicable to this article?

Thanks for your feedback.
Neuronal differentiation
Is the Subject Area "Neuronal differentiation" applicable to this article?

Thanks for your feedback.
Oxidative stress
Is the Subject Area "Oxidative stress" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
Neurons
Is the Subject Area "Neurons" applicable to this article?

Thanks for your feedback.